Renewing Tavalisse (Fostamatinib) Approval with UnitedHealthcare in Washington: Complete 2025 Guide
Answer Box: UnitedHealthcare requires annual renewal of Tavalisse (fostamatinib) prior authorization in Washington, with submissions due 30 days before expiration. Submit via the UHC Provider Portal with documented platelet response, current labs (LFTs, CBC, BP), and hematologist attestation. If denied, file internal appeal within 180 days, then external review through